Skip to main content
. 2021 Jul 28;8(1):152–159. doi: 10.1002/cre2.477

Figure 2.

Figure 2

Association between FoxP3 and HPV expression and survival prognoses. (a) A total of 106 patients were classified using immunohistochemistry as FoxP3 high or low, and overall survival was compared. A significant worsening of survival was observed in FoxP3 high patients (p = 0.04). (b) The same patients were also classified as HPV‐positive or ‐negative, and overall survival was compared; however, the differences were not significant (p = 0.35)